LIVE Bonus Presentations

Tuesday, October 13, 2020

7:00 - 7:45 PM (Eastern)

Studies in Clearance: SKYRIZI for moderate to severe plaque psoriasis (Non-CME) 
Speaker: David J. Cohen
Sponsored By: AbbVie

Wednesday, October 14, 2020

7:00 - 7:45 pm (Eastern)

FDA-Approved Label Expansion Progress Your Topical Patients to the Next Step: An Oral Treatment With Data for Moderate to Severe Scalp Psoriasis (Non-CME) 
Speaker: Miriam Bettencourt, MD
Sponsored By: Amgen

Thursday, October 15, 2020

4:45 pm -5:45 pm (Eastern)

Revolutionizing AD for Children (6-11 Years of Age) With Uncontrolled Moderate-to-Severe Atopic Dermatitis (Non-CME) 
Speaker: Jeffrey Sugarman, MD, PhD
Sponsored by: Regeneron

Friday, October 16, 2020

10:30 am – 11:15 am (Eastern)

Tremfya (guselkumab)
A FIRST-LINE BIOLOGIC IN ADULT PATIENTS WITH MODERAE TO SEVERE PLAQUE PSORIASIS
Now approved for Adults with Active Psoriatic Arthritis (Non-CME) 
Speaker: Stacy Smith, MD
Sponsored by: Janssen